Form 483

Richard E. Colgin, Inc Form 483, 2023-09-21

FDA issued a Form 483 to Richard E. Colgin, Inc on 2023-09-21 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

Richard E. Colgin, Inc · Dallas, United States · Issued September 21, 2023

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Sep 2023
21 CFR 211.103

Actual vs. theoretical yields not determined

Cited by Alan A Rivera

21 Sep 2023
21 CFR 211.165(a)

Testing and release for distribution

Cited by Alan A Rivera

21 Sep 2023
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Alan A Rivera

21 Sep 2023
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Alan A Rivera

21 Sep 2023
21 CFR 211.84(d)(1)

Identity Testing of Each Component

Cited by Alan A Rivera

Inspected site

RERichard E. Colgin, IncDallas, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.103Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(1)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere